Heart pump support for high-risk angioplasty
Part of Heart & circulation clinical trials.
This trial tests the iVAC 2L device, a temporary heart pump placed in the main artery, to help patients who need a high-risk angioplasty (PCI) because of a very narrowed or blocked coronary artery. The goal is to prevent the heart from failing during the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your heart team has decided that your angioplasty has a high risk of causing your heart to collapse.
- You have signed a consent form to participate in the study.
- The artery in your groin (femoral artery) must be at least 6 millimeters wide.
- You cannot have heart failure involving both sides of the heart or mainly the right side.
- You must not have a blood clot in the left lower heart chamber, a mechanical heart valve, or severe aortic valve disease.
- You cannot have severe peripheral artery disease that would block the placement of the pump.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new heart pump (Ventiflow LP) that helps support the heart during a procedure to open blocked coronary arteries (angioplasty or PCI) in people whose hearts are weak. It may help those who are too high risk for bypass surgery.
This trial tests a temporary heart pump (called the KARDION Cory P4) used during a high-risk angioplasty (stenting) procedure. The pump helps keep blood flowing in patients whose heart is weak or who have complex blockages, aiming to make the procedure safer.
This study tests a new device (the VentriCure) that temporarily helps your heart pump during a stent procedure. It is for people with heart failure and blocked arteries who are at high risk for bypass surgery.
This trial tests whether using a small mechanical pump inside the heart plus careful monitoring with a special catheter can help people in shock after a heart attack. It compares this approach to standard care, aiming to improve survival and recovery.
This study tests whether using a special heart pump (called Impella) during a high-risk procedure to open blocked heart arteries can help protect your heart. It aims to see if this support improves the success and safety of the procedure in people with weak hearts.
This trial tests a new device called the Supira system to support the heart during a high-risk procedure to open blocked arteries. It is for people who are stable enough to wait for the procedure (not in emergency or shock).
Hear when a new Ischemic Cardiovascular Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.